Bone turnover marker rhythmicity: implications for osteoporosis treatment and fracture healing
Endocrine Connections · 01.06.2026 · 15 (6)
DOI: 10.1530/ec-26-0114 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Connections, online erschienen am 08.06.2026. Verfasst von Megan M Tidd und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, University of Colorado Anschutz, Aurora, Colorado, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Bone turnover is a dynamic process with markers of bone turnover displaying varying degrees of rhythmicity. The objective of this narrative review was to synthesize current evidence on the regulation of bone turnover marker (BTM) rhythmicity and to evaluate how these rhythms may influence clinically relevant outcomes in osteoporosis treatment and fracture healing. Structured literature searches were conducted in PubMed to identify studies that examined BTM rhythmicity, intrinsic versus extrinsic factors that influence this rhythmicity, and timing effects of osteoporosis medications and fracture-related healing to inform this narrative review. The reviewed evidence demonstrates that markers of bone resorption exhibit robust diurnal rhythms, whereas bone formation markers show lower-amplitude and more variable oscillations. These rhythms are primarily circadian driven and influenced by environmental factors (e.g. fasting) and have important implications for accurate use and interpretation when used clinically and in research. Clinical and preclinical studies further indicate that the administration time of some osteoporosis medications can influence efficacy and safety, with certain anabolic and antiresorptive agents showing differences in biochemical or structural responses depending on administration time, while others appear timing insensitive or remain unstudied. Emerging experimental data suggest that fracture healing may also display rhythmicity and be differentially impacted by the timing of interventions. Plain language summary This review summarizes how bone turnover marker levels vary across the day and night and how this rhythmicity may influence the effects of some medications, with implications for optimal use of these markers in clinical practice and research to improve osteoporosis treatment and potentially fracture healing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, University of Colorado Anschutz, Aurora, Colorado, USA.
- Division of Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz, Aurora, Colorado, USA.
- Geriatric Research, Education and Clinical Center, Rocky Mountain Regional VA, Aurora, Colorado, USA.
ORCID-Profile: Megan M Tidd, Christine M Swanson
Förderung
- National Institutes of Health
Zitieren
APA
Tidd, M. M., & Swanson, C. M. (2026). Bone turnover marker rhythmicity: implications for osteoporosis treatment and fracture healing. Endocrine Connections, 15(6). https://doi.org/10.1530/ec-26-0114
Vancouver
Tidd MM, Swanson CM. Bone turnover marker rhythmicity: implications for osteoporosis treatment and fracture healing. Endocrine Connections. 2026;15(6). doi:10.1530/ec-26-0114
BibTeX
@article{Tidd2026,
author = {Tidd, Megan M and Swanson, Christine M},
title = {Bone turnover marker rhythmicity: implications for osteoporosis treatment and fracture healing},
journal = {Endocrine Connections},
year = {2026},
volume = {15},
number = {6},
doi = {10.1530/ec-26-0114}
}
EUVIMED